The Latest Headlines at American Banking and Market News
A Closer Look At Marsh & McLennan Cos., Inc. (MMC) Quarterly Financial Performance
Revenue growth has increased due to demand for solutions, new business, and global economic factors. Operating expenses rose by 8% to $4.5 billion, driven by higher compensation. Management focuses on risk management and competitive... More of this article »
Beyond the Numbers: Genuine Parts Co. (GPC)
Revenue growth has been positive for Genuine Parts Company over the past three years, driven by the Automotive segment’s performance in European and Australasia businesses. Despite a decline in the Industrial segment due to reduced... More of this article »
CSX Corp. (CSX) Quarterly Financial Filing: What Does It Reveal About Their Future Growth
The company’s revenue decreased by 1% in the first quarter of 2024 due to various factors like lower fuel recovery, pricing declines in export coal, and decreases in other revenue. However, there were pricing gains in merchandise... More of this article »
Nextracker (NXT) – Investment Analysts’ Recent Ratings Changes
Nextracker (NASDAQ: NXT) has recently received a number of price target changes and ratings updates: 4/11/2024 – Nextracker had its price target lowered by analysts at Piper Sandler from $66.00 to $64.00. They now have an “overweight”... More of this article »
Energous (WATT) – Research Analysts’ Weekly Ratings Updates
Energous (NASDAQ: WATT) recently received a number of ratings updates from brokerages and research firms: 4/16/2024 – Energous is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/8/2024... More of this article »
Edgewise Therapeutics (NASDAQ:EWTX) Stock Rating Reaffirmed by Truist Financial
Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Truist Financial in a note issued to investors on Wednesday, Benzinga reports. They currently... More of this article »
Johnson & Johnson (NYSE:JNJ) Price Target Cut to $175.00
Johnson & Johnson (NYSE:JNJ – Get Free Report) had its price objective decreased by equities research analysts at Royal Bank of Canada from $181.00 to $175.00 in a research note issued to investors on Wednesday, Benzinga... More of this article »
Wedbush Reiterates Outperform Rating for Neurocrine Biosciences (NASDAQ:NBIX)
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a report issued on Wednesday, Benzinga reports. They currently have a... More of this article »
Lovesac (NASDAQ:LOVE) Now Covered by Maxim Group
Maxim Group initiated coverage on shares of Lovesac (NASDAQ:LOVE – Get Free Report) in a report issued on Wednesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $36.00 price target on the stock.... More of this article »
Progyny (NASDAQ:PGNY) Rating Reiterated by Truist Financial
Progyny (NASDAQ:PGNY – Get Free Report)‘s stock had its “buy” rating reissued by Truist Financial in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $46.00 price target... More of this article »
Inter Parfums (NASDAQ:IPAR) Rating Reiterated by BWS Financial
Inter Parfums (NASDAQ:IPAR – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at BWS Financial in a research report issued to clients and investors on Wednesday, Benzinga reports.... More of this article »
Haleon (NYSE:HLN) Now Covered by HSBC
Equities researchers at HSBC initiated coverage on shares of Haleon (NYSE:HLN – Get Free Report) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage set a “buy” rating on... More of this article »
The PNC Financial Services Group (NYSE:PNC) Rating Reiterated by Keefe, Bruyette & Woods
The PNC Financial Services Group (NYSE:PNC – Get Free Report)‘s stock had its “underperform” rating reaffirmed by investment analysts at Keefe, Bruyette & Woods in a research report issued to clients and... More of this article »